CHEK2 and breast cancer: Also, a larger 5395 bp germline deletion observed in individuals of Eastern European descent, has been linked to increased risk of breast cancer [1, 4, 5], and recently several germline truncating CHEK2 mutations were linked to risk of Non-Hodgkin Lymphoma [6].